Best Practices and Recommendations for Molecular Testing in Advanced NSCLC (May 2022)

Read expert advice about the importance of managing adjuvant abemaciclib adverse events in early breast cancer, from Clinical Care Options (CCO)

Julia LaBarbera, MSN, RN, AGACNP-BC Released: January 31, 2023

Read expert insights on best practices for incorporating immune checkpoint inhibitor therapy for patients with NSCLC, from Clinical Care Options (CCO)

Julie R. Brahmer, MD
Program Director Jarushka Naidoo, MB BCH BAO, MHS Zofia Piotrowska, MD, MHS Released: January 23, 2023

On-demand webcast from a live satellite symposium at SITC 2022 on current use of IO therapy in lung cancer, from Clinical Care Options (CCO)

Julie R. Brahmer, MD
Program Director Jarushka Naidoo, MB BCH BAO, MHS Zofia Piotrowska, MD, MHS Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: January 17, 2023 Expired: January 16, 2024

Downloadable slides on multidisciplinary approaches to managing high-risk, HR-positive/HER2-negative early breast cancer, from Clinical Care Options, (CCO)

Erika P. Hamilton, MD
Program Director Joyce O'Shaughnessy, MD
Program Director Released: January 4, 2023